T-Cell Therapy Puts Leukemia Patients in Extended Remission

An experimental therapy has brought prolonged remissions to a high proportion of patients who were facing death from advanced leukemia after standard treatments had failed, researchers are reporting.

The therapy involves genetically programming cells from the patient’s own immune system to fight the disease. (more…)